No Picture
Business

China increases bribery claims heat on GSK

By Jamil Anderlini in Beijing and Andrew Jack and George Parker in London China accused GlaxoSmithKline of earning billions of renminbi in “illegal revenues” through a programme of “massive and systemic bribery” as it ratcheted […]